Generic name: siponimod
Used for: Relapsing multiple sclerosis (MS)
Ask for the cash price
Mayzent
We didn’t find one.
Free from the maker, if you qualify Novartis Patient Assistance Foundation (NPAF). Patients must have a household income of less than or equal to $81,760 (for a household size of two) to be considered for NPAF.
Or call 1-800-277-2254.
Details for each option
Savings card from Novartis
Sign up on alongsidemayzent.
“SIGN UP FOR A $0 CO-PAY…”
From the maker’s offer on alongsidemayzent.iassist.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
TrumpRx.gov, the federal government’s drug price site, lists Mayzent at a price its maker agreed to, for people paying without insurance.
From TrumpRx.gov, read October 28, 2026. Its page opens on this price; other strengths and amounts are priced there too. With insurance, check your co-pay first: it may be lower.
There isn’t one. An authorized generic is Mayzent itself, from the same company, sold without the brand name, and usually for less. For now Mayzent is the only choice; its maker’s savings card can lower what you pay.
We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.
MAYZENT is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Source: the FDA label for Mayzent (Novartis Pharmaceuticals Corporation), June 30, 2026. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/mayzent/